INCYTE CORPORATION Accounts Payable
INCYTE CORPORATION (INCY) had Accounts Payable of $228.62 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-04-28
- 2026-03-31: Accounts Payable, Current $228.62M.
- 2025-12-31: Accounts Payable, Current $209.94M.
- 2025-09-30: Accounts Payable, Current $171.93M.
- 2025-06-30: Accounts Payable, Current $241.09M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-03-31 | $228.62M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $209.94M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $171.93M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $241.09M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $195.54M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $197.47M 10-K · filed 2026-02-10 |
| 2024-09-30 | $178.71M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $148.17M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $164.24M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $109.60M 10-K · filed 2025-02-10 |
| 2023-09-30 | $139.41M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $155.54M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $55.63M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $277.55M 10-K · filed 2024-02-13 |
| 2022-09-30 | $163.18M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $194.77M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $152.55M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $172.11M 10-K · filed 2023-02-07 |
| 2021-09-30 | $114.51M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $122.10M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $85.06M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $98.77M 10-K · filed 2022-02-08 |
| 2020-09-30 | $122.51M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $90.91M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $60.94M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $83.65M 10-K · filed 2021-02-09 |
| 2019-09-30 | $95.38M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $66.18M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $70.36M 10-Q · filed 2019-04-30 |
| 2018-12-31 | $103.83M 10-K · filed 2020-02-13 |
| 2018-09-30 | $95.48M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $75.56M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $74.11M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $67.67M 10-K · filed 2019-02-14 |
| 2017-09-30 | $69.93M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $69.09M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $86.33M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $75.60M 10-K · filed 2018-02-15 |
| 2016-09-30 | $57.52M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $40.72M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $31.90M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $30.09M 10-K · filed 2017-02-14 |
| 2015-09-30 | $27.37M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $29.16M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $26.59M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $24.46M 10-K · filed 2016-02-12 |
| 2014-09-30 | $26.61M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $27.25M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $17.95M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $19.10M 10-K · filed 2015-02-17 |
| 2013-09-30 | $18.21M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $13.47M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $15.52M 10-Q · filed 2013-05-02 |
| 2012-12-31 | $13.96M 10-K · filed 2014-02-21 |
| 2012-09-30 | $12.76M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $11.10M 10-Q · filed 2012-08-03 |
| 2012-03-31 | $13.17M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $14.94M 10-K · filed 2013-02-21 |
| 2011-09-30 | $11.04M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $8.79M 10-Q · filed 2011-07-28 |
| 2011-03-31 | $7.79M 10-Q · filed 2011-05-03 |
| 2010-12-31 | $10.77M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |